The company, founded by the Mayo Clinic, develops radiopharmaceuticals to treat tumors with more precision.

Press/Media

Period	Oct 17 2023

Media coverage

Title	The company, founded by the Mayo Clinic, develops radiopharmaceuticals to treat tumors with more precision.
Media name/outlet	Philadelphia Inquirer
Country/Territory	United States
Date	10/17/23
URL	https://www.inquirer.com/health/fox-chase-mayo-clinic-nucleus-radiopharma-20231017.html
Persons	Robert G. Uzzo